Mendra Funding: $82M Raised, Series A (2026)

Mendra is a Biotech company based in San Francisco. It has raised $82M in total funding. Latest round: Series A. Backed by OrbiMed, 8VC, 5AM Ventures.

Mendra funding overview

Mendra is a Biotech company based in San Francisco. Mendra has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2026. The round record for Mendra runs through 2026; nothing later has been disclosed. Investors on record include OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC. 5 distinct backers are named across the disclosed rounds.

Mendra at a glance

Total raised
$82M
Latest round
Series A
Latest round date
January 2026
Industry
Biotech
Headquarters
San Francisco
Notable investors
OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC

Frequently asked about Mendra funding

How much has Mendra raised?
Mendra has raised $82M in total disclosed funding across the rounds on record.
Who has invested in Mendra?
OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC are named among the investors backing Mendra.
What was the latest Mendra funding round?
The most recent disclosed round is a Series A, announced in January 2026.
Where is Mendra based?
Mendra is based in San Francisco.
What sector does Mendra operate in?
Mendra is tracked under Biotech from San Francisco, with $82M in disclosed funding.
When did Mendra last raise?
The last disclosed Mendra round closed in January 2026 at Series A.

We update the Mendra record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Francisco and their backers are listed below.

Mendra founders (1)

Companies related to Mendra (40)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026